بدائل البحث:
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
greater decrease » greatest decrease (توسيع البحث), greater increase (توسيع البحث), greater disease (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
-
1021
-
1022
-
1023
Univariate and multivariate analysis of variables associated with good and poor responders to TFESI.
منشور في 2025الموضوعات: -
1024
-
1025
The serum concentrations of cytokines between good responders and poor responders to TFESI.
منشور في 2025الموضوعات: -
1026
Demographic data and baseline characteristics between good and poor responders to TFESI.
منشور في 2025الموضوعات: -
1027
-
1028
-
1029
<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate....
منشور في 2025"…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …"
-
1030
Survey-weighted association of flavonoids and six subclasses intake with MASLD.
منشور في 2025الموضوعات: -
1031
-
1032
-
1033
-
1034
-
1035
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
منشور في 2025"…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …"
-
1036
-
1037
-
1038
-
1039
-
1040